WO2024011043A1 - Nutritional composition - Google Patents
Nutritional composition Download PDFInfo
- Publication number
- WO2024011043A1 WO2024011043A1 PCT/US2023/069231 US2023069231W WO2024011043A1 WO 2024011043 A1 WO2024011043 A1 WO 2024011043A1 US 2023069231 W US2023069231 W US 2023069231W WO 2024011043 A1 WO2024011043 A1 WO 2024011043A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- nutritional composition
- palmitic
- oil
- sunflower oil
- acid
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 140
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 105
- 235000019486 Sunflower oil Nutrition 0.000 claims abstract description 82
- 239000002600 sunflower oil Substances 0.000 claims abstract description 82
- 239000003921 oil Substances 0.000 claims abstract description 45
- 235000019198 oils Nutrition 0.000 claims abstract description 45
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 claims abstract description 35
- 125000005313 fatty acid group Chemical group 0.000 claims abstract description 33
- 239000004615 ingredient Substances 0.000 claims abstract description 19
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 claims abstract description 14
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 claims abstract description 14
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 claims abstract description 14
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 claims abstract description 14
- 239000005642 Oleic acid Substances 0.000 claims abstract description 14
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 claims abstract description 14
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 claims abstract description 14
- 235000020778 linoleic acid Nutrition 0.000 claims abstract description 14
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 claims abstract description 14
- 235000021314 Palmitic acid Nutrition 0.000 claims abstract description 13
- WQEPLUUGTLDZJY-UHFFFAOYSA-N n-Pentadecanoic acid Natural products CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 claims abstract description 13
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 claims abstract description 13
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 claims abstract description 5
- 235000021355 Stearic acid Nutrition 0.000 claims abstract description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 claims abstract description 4
- 239000008117 stearic acid Substances 0.000 claims abstract description 4
- 235000003222 Helianthus annuus Nutrition 0.000 claims description 15
- 235000019482 Palm oil Nutrition 0.000 claims description 15
- 239000002540 palm oil Substances 0.000 claims description 15
- 241000208818 Helianthus Species 0.000 claims description 14
- 235000018102 proteins Nutrition 0.000 claims description 14
- 108090000623 proteins and genes Proteins 0.000 claims description 14
- 102000004169 proteins and genes Human genes 0.000 claims description 14
- 235000013350 formula milk Nutrition 0.000 claims description 11
- 229940088594 vitamin Drugs 0.000 claims description 8
- 229930003231 vitamin Natural products 0.000 claims description 8
- 235000013343 vitamin Nutrition 0.000 claims description 8
- 239000011782 vitamin Substances 0.000 claims description 8
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 claims description 6
- 150000001720 carbohydrates Chemical class 0.000 claims description 6
- 235000014633 carbohydrates Nutrition 0.000 claims description 6
- 239000002253 acid Substances 0.000 claims description 5
- 241000196324 Embryophyta Species 0.000 claims description 4
- 235000020776 essential amino acid Nutrition 0.000 claims description 4
- 239000003797 essential amino acid Substances 0.000 claims description 4
- 235000004626 essential fatty acids Nutrition 0.000 claims description 4
- 235000020661 alpha-linolenic acid Nutrition 0.000 claims description 3
- 235000020218 follow-on milk formula Nutrition 0.000 claims description 3
- 229960004488 linolenic acid Drugs 0.000 claims description 3
- WWZKQHOCKIZLMA-UHFFFAOYSA-N octanoic acid Chemical compound CCCCCCCC(O)=O WWZKQHOCKIZLMA-UHFFFAOYSA-N 0.000 claims description 3
- 239000000460 chlorine Substances 0.000 description 19
- 239000003925 fat Substances 0.000 description 19
- 235000019197 fats Nutrition 0.000 description 19
- 235000014113 dietary fatty acids Nutrition 0.000 description 9
- 239000000194 fatty acid Substances 0.000 description 9
- 229930195729 fatty acid Natural products 0.000 description 9
- 235000013311 vegetables Nutrition 0.000 description 9
- 241001465754 Metazoa Species 0.000 description 8
- 150000004665 fatty acids Chemical class 0.000 description 8
- 235000020256 human milk Nutrition 0.000 description 7
- 235000021243 milk fat Nutrition 0.000 description 7
- 241000283690 Bos taurus Species 0.000 description 6
- 210000004251 human milk Anatomy 0.000 description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 description 6
- 239000011707 mineral Substances 0.000 description 6
- 235000010755 mineral Nutrition 0.000 description 6
- 150000002632 lipids Chemical class 0.000 description 5
- 229920001542 oligosaccharide Polymers 0.000 description 5
- 229920001282 polysaccharide Polymers 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- 108010073771 Soybean Proteins Proteins 0.000 description 4
- 235000001014 amino acid Nutrition 0.000 description 4
- 229940024606 amino acid Drugs 0.000 description 4
- 150000001413 amino acids Chemical class 0.000 description 4
- 235000019519 canola oil Nutrition 0.000 description 4
- 239000000828 canola oil Substances 0.000 description 4
- 235000019868 cocoa butter Nutrition 0.000 description 4
- 229940110456 cocoa butter Drugs 0.000 description 4
- 235000012343 cottonseed oil Nutrition 0.000 description 4
- 239000002385 cottonseed oil Substances 0.000 description 4
- 235000005911 diet Nutrition 0.000 description 4
- 230000037213 diet Effects 0.000 description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 4
- 150000004676 glycans Chemical class 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 230000035764 nutrition Effects 0.000 description 4
- 150000002482 oligosaccharides Chemical class 0.000 description 4
- 239000005017 polysaccharide Substances 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 230000008569 process Effects 0.000 description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 4
- 229940001941 soy protein Drugs 0.000 description 4
- PHYFQTYBJUILEZ-IUPFWZBJSA-N triolein Chemical compound CCCCCCCC\C=C/CCCCCCCC(=O)OCC(OC(=O)CCCCCCC\C=C/CCCCCCCC)COC(=O)CCCCCCC\C=C/CCCCCCCC PHYFQTYBJUILEZ-IUPFWZBJSA-N 0.000 description 4
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 3
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 3
- DCXXMTOCNZCJGO-UHFFFAOYSA-N Glycerol trioctadecanoate Natural products CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 3
- 241000282412 Homo Species 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 235000019864 coconut oil Nutrition 0.000 description 3
- 239000003240 coconut oil Substances 0.000 description 3
- 235000013365 dairy product Nutrition 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- IPCSVZSSVZVIGE-UHFFFAOYSA-M hexadecanoate Chemical compound CCCCCCCCCCCCCCCC([O-])=O IPCSVZSSVZVIGE-UHFFFAOYSA-M 0.000 description 3
- 230000004060 metabolic process Effects 0.000 description 3
- 150000002772 monosaccharides Chemical class 0.000 description 3
- 235000006180 nutrition needs Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 239000005905 Hydrolysed protein Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000002720 Malnutrition Diseases 0.000 description 2
- 108010011756 Milk Proteins Proteins 0.000 description 2
- 102000014171 Milk Proteins Human genes 0.000 description 2
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 description 2
- 235000019485 Safflower oil Nutrition 0.000 description 2
- MBMBGCFOFBJSGT-KUBAVDMBSA-N all-cis-docosa-4,7,10,13,16,19-hexaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 2
- -1 all-trans-retinol Chemical compound 0.000 description 2
- 230000000172 allergic effect Effects 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 239000011648 beta-carotene Substances 0.000 description 2
- 235000013734 beta-carotene Nutrition 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 235000019577 caloric intake Nutrition 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 235000020774 essential nutrients Nutrition 0.000 description 2
- 235000019152 folic acid Nutrition 0.000 description 2
- 239000011724 folic acid Substances 0.000 description 2
- 235000021255 galacto-oligosaccharides Nutrition 0.000 description 2
- 150000003271 galactooligosaccharides Chemical class 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 239000000944 linseed oil Substances 0.000 description 2
- 235000021388 linseed oil Nutrition 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000011785 micronutrient Substances 0.000 description 2
- 235000013369 micronutrients Nutrition 0.000 description 2
- 230000003278 mimic effect Effects 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 235000018343 nutrient deficiency Nutrition 0.000 description 2
- 239000004006 olive oil Substances 0.000 description 2
- 235000008390 olive oil Nutrition 0.000 description 2
- 239000003346 palm kernel oil Substances 0.000 description 2
- 235000019865 palm kernel oil Nutrition 0.000 description 2
- 239000002245 particle Substances 0.000 description 2
- 235000010987 pectin Nutrition 0.000 description 2
- 239000001814 pectin Substances 0.000 description 2
- 229920001277 pectin Polymers 0.000 description 2
- 229920005862 polyol Polymers 0.000 description 2
- 150000003077 polyols Chemical class 0.000 description 2
- 244000144977 poultry Species 0.000 description 2
- 235000013594 poultry meat Nutrition 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 235000005713 safflower oil Nutrition 0.000 description 2
- 239000003813 safflower oil Substances 0.000 description 2
- 235000003441 saturated fatty acids Nutrition 0.000 description 2
- 150000004671 saturated fatty acids Chemical class 0.000 description 2
- 235000012424 soybean oil Nutrition 0.000 description 2
- 239000003549 soybean oil Substances 0.000 description 2
- 235000020238 sunflower seed Nutrition 0.000 description 2
- 229940011671 vitamin b6 Drugs 0.000 description 2
- MJYQFWSXKFLTAY-OVEQLNGDSA-N (2r,3r)-2,3-bis[(4-hydroxy-3-methoxyphenyl)methyl]butane-1,4-diol;(2r,3r,4s,5s,6r)-6-(hydroxymethyl)oxane-2,3,4,5-tetrol Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O.C1=C(O)C(OC)=CC(C[C@@H](CO)[C@H](CO)CC=2C=C(OC)C(O)=CC=2)=C1 MJYQFWSXKFLTAY-OVEQLNGDSA-N 0.000 description 1
- ZFTFOHBYVDOAMH-XNOIKFDKSA-N (2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-5-[[(2r,3s,4s,5r)-3,4-dihydroxy-2,5-bis(hydroxymethyl)oxolan-2-yl]oxymethyl]-3,4-dihydroxy-2-(hydroxymethyl)oxolan-2-yl]oxymethyl]-2-(hydroxymethyl)oxolane-2,3,4-triol Chemical class O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@@H]1[C@@H](O)[C@H](O)[C@](CO)(OC[C@@H]2[C@H]([C@H](O)[C@@](O)(CO)O2)O)O1 ZFTFOHBYVDOAMH-XNOIKFDKSA-N 0.000 description 1
- GJJVAFUKOBZPCB-ZGRPYONQSA-N (r)-3,4-dihydro-2-methyl-2-(4,8,12-trimethyl-3,7,11-tridecatrienyl)-2h-1-benzopyran-6-ol Chemical class OC1=CC=C2OC(CC/C=C(C)/CC/C=C(C)/CCC=C(C)C)(C)CCC2=C1 GJJVAFUKOBZPCB-ZGRPYONQSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- PVXPPJIGRGXGCY-TZLCEDOOSA-N 6-O-alpha-D-glucopyranosyl-D-fructofuranose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)C(O)(CO)O1 PVXPPJIGRGXGCY-TZLCEDOOSA-N 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 1
- 244000266618 Atriplex confertifolia Species 0.000 description 1
- 235000012137 Atriplex confertifolia Nutrition 0.000 description 1
- 241001474374 Blennius Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 description 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 description 1
- 244000045195 Cicer arietinum Species 0.000 description 1
- 235000010523 Cicer arietinum Nutrition 0.000 description 1
- 244000298479 Cichorium intybus Species 0.000 description 1
- 235000007542 Cichorium intybus Nutrition 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000219992 Cuphea Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000004386 Erythritol Substances 0.000 description 1
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 1
- 241000132179 Eurotium medium Species 0.000 description 1
- 206010016946 Food allergy Diseases 0.000 description 1
- 229920002670 Fructan Polymers 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 229920000926 Galactomannan Polymers 0.000 description 1
- 208000027472 Galactosemias Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 244000020551 Helianthus annuus Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 229920001202 Inulin Polymers 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 201000010538 Lactose Intolerance Diseases 0.000 description 1
- 235000014647 Lens culinaris subsp culinaris Nutrition 0.000 description 1
- 244000043158 Lens esculenta Species 0.000 description 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 239000005913 Maltodextrin Substances 0.000 description 1
- 229920002774 Maltodextrin Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 108010084695 Pea Proteins Proteins 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 229920001100 Polydextrose Polymers 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 235000019484 Rapeseed oil Nutrition 0.000 description 1
- 229920000294 Resistant starch Polymers 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 description 1
- DBMJMQXJHONAFJ-UHFFFAOYSA-M Sodium laurylsulphate Chemical compound [Na+].CCCCCCCCCCCCOS([O-])(=O)=O DBMJMQXJHONAFJ-UHFFFAOYSA-M 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- JZRWCGZRTZMZEH-UHFFFAOYSA-N Thiamine Natural products CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N JZRWCGZRTZMZEH-UHFFFAOYSA-N 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 229930003761 Vitamin B9 Natural products 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- 235000019498 Walnut oil Nutrition 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- ANVAOWXLWRTKGA-XHGAXZNDSA-N all-trans-alpha-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1C(C)=CCCC1(C)C ANVAOWXLWRTKGA-XHGAXZNDSA-N 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 208000030961 allergic reaction Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 239000010775 animal oil Substances 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 239000007900 aqueous suspension Substances 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940071162 caseinate Drugs 0.000 description 1
- 230000001925 catabolic effect Effects 0.000 description 1
- 235000013351 cheese Nutrition 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- 229940010007 cobalamins Drugs 0.000 description 1
- 150000001867 cobalamins Chemical class 0.000 description 1
- 239000010941 cobalt Substances 0.000 description 1
- 229910017052 cobalt Inorganic materials 0.000 description 1
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 1
- FDJOLVPMNUYSCM-UVKKECPRSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2,7, Chemical compound [Co+3].N#[C-].C1([C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)[N-]\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O FDJOLVPMNUYSCM-UVKKECPRSA-L 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 235000014510 cooky Nutrition 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 235000020247 cow milk Nutrition 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 235000013681 dietary sucrose Nutrition 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000009429 distress Effects 0.000 description 1
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 235000013601 eggs Nutrition 0.000 description 1
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 235000019414 erythritol Nutrition 0.000 description 1
- 229940009714 erythritol Drugs 0.000 description 1
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 1
- 235000021112 essential micronutrients Nutrition 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 235000019688 fish Nutrition 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940014144 folate Drugs 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- ZZUFCTLCJUWOSV-UHFFFAOYSA-N furosemide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC(C(O)=O)=C1NCC1=CC=CO1 ZZUFCTLCJUWOSV-UHFFFAOYSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- VZCCETWTMQHEPK-UHFFFAOYSA-N gamma-Linolensaeure Natural products CCCCCC=CCC=CCC=CCCCCC(O)=O VZCCETWTMQHEPK-UHFFFAOYSA-N 0.000 description 1
- VZCCETWTMQHEPK-QNEBEIHSSA-N gamma-linolenic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/CCCCC(O)=O VZCCETWTMQHEPK-QNEBEIHSSA-N 0.000 description 1
- 235000020664 gamma-linolenic acid Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229960002733 gamolenic acid Drugs 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 238000000265 homogenisation Methods 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- 230000000774 hypoallergenic effect Effects 0.000 description 1
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 description 1
- 229940029339 inulin Drugs 0.000 description 1
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- 230000000366 juvenile effect Effects 0.000 description 1
- 208000017169 kidney disease Diseases 0.000 description 1
- 229940106134 krill oil Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 239000000832 lactitol Substances 0.000 description 1
- 235000010448 lactitol Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 229960003451 lactitol Drugs 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 235000019860 lauric fat Nutrition 0.000 description 1
- 235000020997 lean meat Nutrition 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 208000018773 low birth weight Diseases 0.000 description 1
- 231100000533 low birth weight Toxicity 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011738 major mineral Substances 0.000 description 1
- 235000011963 major mineral Nutrition 0.000 description 1
- 229940035034 maltodextrin Drugs 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 229960001855 mannitol Drugs 0.000 description 1
- 235000012054 meals Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 235000021239 milk protein Nutrition 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 235000019426 modified starch Nutrition 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000019895 oat fiber Nutrition 0.000 description 1
- 150000002889 oleic acids Chemical class 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020665 omega-6 fatty acid Nutrition 0.000 description 1
- 229940033080 omega-6 fatty acid Drugs 0.000 description 1
- 230000004963 pathophysiological condition Effects 0.000 description 1
- 235000019702 pea protein Nutrition 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 1
- 230000008635 plant growth Effects 0.000 description 1
- 239000001259 polydextrose Substances 0.000 description 1
- 235000013856 polydextrose Nutrition 0.000 description 1
- 229940035035 polydextrose Drugs 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000015277 pork Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 235000011962 puddings Nutrition 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- 150000004053 quinones Chemical class 0.000 description 1
- 235000021254 resistant starch Nutrition 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 239000011669 selenium Substances 0.000 description 1
- 229910052711 selenium Inorganic materials 0.000 description 1
- 239000008159 sesame oil Substances 0.000 description 1
- 235000011803 sesame oil Nutrition 0.000 description 1
- 235000021391 short chain fatty acids Nutrition 0.000 description 1
- 150000004666 short chain fatty acids Chemical class 0.000 description 1
- 235000011888 snacks Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 235000019157 thiamine Nutrition 0.000 description 1
- KYMBYSLLVAOCFI-UHFFFAOYSA-N thiamine Chemical compound CC1=C(CCO)SCN1CC1=CN=C(C)N=C1N KYMBYSLLVAOCFI-UHFFFAOYSA-N 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 239000011721 thiamine Substances 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 125000002640 tocopherol group Chemical class 0.000 description 1
- 235000019149 tocopherols Nutrition 0.000 description 1
- 229930003802 tocotrienol Natural products 0.000 description 1
- 239000011731 tocotrienol Substances 0.000 description 1
- 229940068778 tocotrienols Drugs 0.000 description 1
- 235000019148 tocotrienols Nutrition 0.000 description 1
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000021470 vitamin B5 (pantothenic acid) Nutrition 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 235000021467 vitamin B7(Biotin) Nutrition 0.000 description 1
- 235000019159 vitamin B9 Nutrition 0.000 description 1
- 239000011727 vitamin B9 Substances 0.000 description 1
- 235000019166 vitamin D Nutrition 0.000 description 1
- 239000011710 vitamin D Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 150000003703 vitamin D2 derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940045999 vitamin b 12 Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000008170 walnut oil Substances 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 235000021119 whey protein Nutrition 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000013618 yogurt Nutrition 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
- A23D7/00—Edible oil or fat compositions containing an aqueous phase, e.g. margarines
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
Definitions
- the present invention relates to a nutritional composition
- a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient.
- Nutritional compositions are compositions that are developed to cover the nutritional needs, of specific groups of people, such as preterm infants, infants, toddlers, elderly people, athletes, or human subjects having nutritional deficiencies and/or having a deficient immune system.
- Nutritional compositions for early life nutrition aim to resemble human milk as much as possible, since human milk is generally seen as the ideal source of nutrition during early life.
- Early life nutrition and more specifically infant formula are nutritional compositions for formula-fed infants allowing a comparable growth and development as an exclusively breastfed infant. For this reason, in the early life compositions, not only the mam nutrients (proteins, lipids and carbohydrates), but also the trace elements (minerals, vitamins and etc.), must be carefully prepared to meet the infants’ nutritional needs.
- One aspect wherein the nutritional compositions tend to resemble human milk fat as close as possible is its fatty acid profile.
- a combination of vegetable and animal oils and/or fats may be used, including bovine milk fat, palm oil, palm oil fractions or combinations of two or more thereof.
- the present invention relates to a nutritional composition
- a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient
- the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 20.0 to 45.0 wt.%, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising:
- the present invention further relates to the use of high-palmitic sunflower oil in a nutritional composition
- the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (C16) in an amount of from 20.0 to 45.0 wt.%
- the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a fatty acid moiety comprising oleic acid (Cl 8.1) in a range of from 45.0 to 65.0 wt.%
- the high palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition
- the present invention relates to a nutritional composition
- a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient.
- high-palmitic sunflower oil in the present invention is encompassing sunflower oils having a fatty acid moiety comprising palmitic acid (C16) in an amount of from 20.0 to 45.0 wt.%, from 22.0 to 40.0 wt.%, or from 25 to 34.7 wt.%, and wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising:
- nutritional compositions may be helpful for people who struggle with a loss of appetite, have difficulty in chewing, have trouble preparing balanced meals, and/or are recovering from surgery or illness.
- the nutritional composition is meant for a complete nutrition, it can provide a healthy balance of protein, carbohydrate, and/or fat.
- the nutritional compositions according to the invention may be in the form of a liquid, as a ready -to-drink nutritional composition, or used in feeding tubes. It can also be in the form of a formula base, i.e. a powder or a concentrated liquid, to be dissolved in water or in another fluid for the preparation of a ready-to-drink nutritional composition.
- the nutritional composition may also be in the form of a pudding or a j elly, or in the form of a cookie or a snack bar, or in any other form.
- the nutritional composition is a ready-to-drink nutritional composition, or a powder.
- the nutntional composition according to the present invention is an early life nutritional composition, i.e. a composition that is particularly suitable for human subjects of 0 to 36 months of age.
- the early life nutritional composition according to the present invention may be an infant formula (first age), for infants from birth to age of 6 months; a follow-on formula (second age), for infants from an age of 6 to 18 months, or a growing-up formula (third age) for infants from an age from 1 to 3 years.
- first age infant formula
- second age follow-on formula
- third age growing-up formula
- the early life nutritional composition is a follow-on formula or growing-up formula.
- early life nutritional composition according to the invention prepared for special medical purposes are nutrient-dense formulae enhanced in proteins, fats, minerals and vitamins for premature infants or low-birth-weight and elemental formulae, using free amino acids instead of proteins or peptides, for infants who are allergic to hydrolysed protein or soy, and the like.
- the high-palmitic sunflower oil is a mixture of 2 or more high-palmitic sunflower oils.
- a mixture of 2 or more high-palmitic sunflower oils it is understood that the fatty acid moiety of the mixture of the 2 or more high-palmitic sunflower oils has a content of palmitic acid (C16) in a range of from 20.0 to 45.0 wt.%, from 22.0 to 40.0 wt.%, or from 25 to 34.7 wt.%.
- the high-palmitic sunflower oil may be sourced from oilseeds of any sunflower (Helianthus annuus) line bearing oil which exhibits, following crushing and extraction, and in the absence of hydrogenation, or other chemical or physical modification, a fatty acid moiety having a suitable content of Cl 6.
- suitable sunflower oilseed lines are, but are not limited to, sunflower oilseed line IG-1297M or QQ-3598-M (EPl 185161), CAS-5 or CAS-12 (Serrano- Vega, M. (2005) Lipids, Vol. 40, p 369-374)
- the high palmitic sunflower oil is a mixture of a high- palmitic high-oleic sunflower oil and a high-palmitic high-linoleic sunflower oil
- high-palmitic high-oleic sunflower oil is encompassing high-palmitic sunflower oil having a fatty acid moiety comprising oleic acid (C18.1) in a range of from 45.0 to 65.0 wt.%, from 48.0 to 62.0 wt.%, or from 50.0 to 60.0 wt.%.
- High-palmitic high-oleic sunflower oil may be sourced from oilseeds of a sunflower line such as, but not limited to, CAS-12, IG- 1297M or QQ-3598-M or a mixture of two or more thereof.
- high-palmitic high-linoleic sunflower oil is encompassing high-palmitic sunflower having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of from 35.0 to 55.0 wt.%, from 37.0 to 52.0 wt.%, or from 40.0 to 50.0 wt.%.
- High-palmitic high-linoleic sunflower oil may be sourced from oilseeds of a sunflower line such as CAS-5 or the like.
- the high-palmitic sunflower oil may be present in an amount of from 25 to 95 wt.%, from 30 to 90 wt.% or from 35 to 80 wt.% of the total oil and/or fat content of the nutritional composition.
- the high-palmitic sunflower oil is a mixture of a high-palmitic high- oleic sunflower oil and a high-palmitic high-linoleic sunflower oil, whereby the ratio of oleic acid over linoleic acid (C18.1/C18.2) is in a range of from 0.5 to 8.0, from 1.0 to 7.5, or from 1.5 to 6.5.
- the high-palmitic sunflower oil is present as free oil in the nutritional composition.
- the high-palmitic sunflower oil is present in the form of isolated or enlarged sunflower oleosomes.
- Oleosomes also known as “oil bodies”, “lipid bodies”, “lipid droplets” or “spherosomes", are pre-emulsified droplets or vesicles of oil stored in plant seeds and used as energy source for plant growth and metabolism. Oleosomes are typically extracted from cells by a process of grinding the seeds and subsequently washing, filtering and homogenizing the ground seeds to form an aqueous suspension. Said suspension is centrifuged to separate the oleosomes, called isolated oleosomes.
- isolated oleosomes means oleosomes that have been isolated/removed from their natural source of high-palmitic sunflower seeds.
- the term encompasses oleosomes isolated from a single oilseed line, as well as blends of oleosomes that are isolated from more than one oilseed line.
- isolated high-palmitic sunflower oleosomes in the nutritional composition of the present invention may have an average globule diameter of about 1.5 to 2.5 micron.
- Enlarged oleosomes as used in the present description means oleosomes that have been isolated/removed from their natural source and that have been subsequently subjected to a process for increasing their average globule size. Examples of processes for enlarging the average globule size of oleosomes are for example described in WO2021126408.
- the enlarged high-palmitic sunflower oleosomes in the nutritional composition of the present invention may have an average globule diameter of the oleosomes in a range of from more than 2.5 to 15.0 micron, preferably from 3.0 to 12.0 micron, more preferably from 4.0 to 10.0 micron. Such a globule size is important when being used for an early life nutritional composition, since it mimics the average globule size of human breast milk of about 5.0 micron.
- the average globule diameter of isolated or enlarged oleosomes is expressed as the D50-value (D50).
- D50-value the average globule diameter of the oleosomes
- the oleosomes are considered spherical and in case of non-spherical oleosomes, the diameter is considered as being the largest dimension that can be measured between two opposite points on the surface thereof.
- a Mastersizer 3000 from Malvern equipped with a Hydro module may be used.
- a refractive index of 1.47 is used to measure the oleosomes size.
- the concentration of the oleosomes in the buffer is such that an obscuration in the range from 8.0 to 8.5% in the Mastersizer equipment is obtained. Obscuration within the Mastersizer is the amount of light blocked or scattered, by the particles. Therefore, the oleosomes are diluted in a buffer solution containing 10 mM sodium phosphate, pH 7.4, and 1.0 weight% sodium dodecyl sulphate (SDS).
- SDS sodium dodecyl sulphate
- the nutritional composition may further comprise oils and/or fats other than the high-palmitic sunflower oil.
- Sources of such oils and/orfats other than the high-palmitic sunflower oil may be from vegetable and/or animal origin or a combination thereof. These sources do not compnse high-palmitic sunflower oil having a fatty acid moiety with a content of palmitic acid (Cl 6) in a range of from 20 to 45 wt.%.
- Sources of oils and/or fats other than the high-palmitic sunflower oil from animal origin include, but are not limited to milk fat, pork fat (lard), cattle and sheep fat (tallow), poultry fat, fish oil, krill oil and combinations of two or more thereof.
- Sources of these fats, other than the high-palmitic sunflower oil, from vegetable origin include, without any limitation, cocoa butter, com oil, cottonseed oil, groundnut oil, linseed oil, olive oil, palm, palm olein, palm stearin, rapeseed oil, high-oleic canola oil, rice bran oil, safflower oil (also known as flaxseed oil), sesame oil, soybean oil, sunflower oil, including mid- and high-oleic varieties of sunflower, high-stearic sunflower oil, coconut oil, palm kernel oil, MCT compositions (i.e. Medium Chain Triglyceride with fatty acid chain lengths in range of C8 to C12), algae oil, yeast oil, and combinations of two or more thereof.
- cocoa butter com oil
- cottonseed oil groundnut oil
- linseed oil olive oil
- palm palm olein
- palm stearin palm stearin
- rapeseed oil high-oleic canola
- Oils, fats, or combinations of oils and/or fats other than the high-palmitic sunflower oil may be present to obtain the desired composition of fatty acids in the nutritional composition together with the high-palmitic sunflower oil. Especially a desired amount of mono- and polyunsaturated fatty acids and/or a desired amount of mid- and short chain fatty acids is targeted.
- the total oil and/or fat content of the nutritional composition has a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 15 to 30 wt.%, from 16 to 28 wt.%, or from 18 to 26 wt.%.
- palmitic acid Cl 6
- other sources of palmitic acid that may be comprised in the nutritional composition are amongst others palm oil, cottonseed oil, cocoa butter, illipe fat; olein or stearin fractions of palm oil, cottonseed oil, cocoa butter or illipe fat; and blends of 2 or more thereof.
- the nutritional composition is substantially free from palm oil or components sourced from palm oil.
- Components sourced from palm oil are for example single or multiple fractionated oleins, single or multiple fractionated stearins, palm mid fractions, interesterified palm, interesterified palm fractions, hydrogenated palm, hydrogentated palm fractions, any combination of 2 or more thereof, and the like.
- other vegetable sources of oleic acid Cl 8.1 that may be comprised in the nutritional composition are amongst others high- oleic or mid-oleic sunflower oil, high-oleic canola oil, high-stearic high-oleic sunflower oil, olive oil, palm oil and olein fractions (single or multiple fractions) of palm oil, or a mixture of 2 or more thereof.
- Animal sources of oleic acid may be, but are not limited to, chicken fat or lard or a mixture of 2 or more thereof.
- the total oil and/or fat content of the nutritional composition may have a fatty acid moiety that is further comprising caprylic (C8), capric (CIO), lauric (C12) and myristic (C14) acid in a combined content (C8+C10+C12+C14) of up to 20 wt.%, from 10 to 18 wt.%, or from 12 to 16 wt.%.
- Sources of caprylic (C8), capric (CIO), lauric (C12) and/or myristic (C14) acid that may be comprised in the nutritional composition are typically lauric fats such as for example coconut oil, palmkemel oil; olein or stearin fractions of coconut oil or palmkernel oil; MCT compositions; cuphea oil, or a mixture of 2 or more thereof.
- the total oil and/or fat content of the nutritional composition may have a fatty acid moiety that is further comprising alpha-linolenic acid (Cl 8.3) in a range of from 0.5 to 4.0 wt.%, from 0.6 to 3.5 wt.%, or from 0.7 to 3.0 wt.%.
- alpha-linolenic acid Cl 8.3
- Sources of Cl 8.3 that may be comprised in the nutritional composition are, but are not limited to flaxseed, canola oil, walnut oil or mixtures of 2 or more thereof.
- the nutritional composition according to the invention comprises at least one nutritional ingredient other than the high-palmitic sunflower oil.
- Nutritional ingredients are ingredients that contribute to the caloric intake and/or provide micronutrients.
- the at least one other nutritional ingredient of the nutritional composition according to the invention is selected from the group consisting of proteins, carbohydrates, minerals, trace elements, essential amino acids, essential fatty acids, vitamins, and mixtures of two or more thereof. More preferably, the at least one other nutritional ingredient is selected from the group consisting of proteins, carbohydrates, essential amino acids, essential fatty acids, vitamins, and mixtures of two or more thereof.
- Sources of proteins may be from vegetable and/or animal origin.
- Protein sources from animal origin include, but are not limited to, lean meat, poultry, fish, eggs or dairy products like milk, yoghurt, cheese, whey proteins or caseinate.
- Protein sources from vegetable origin include, without any limitation, seeds, nuts, beans, legumes, such as lentils and chickpeas, grain and cereal-based products. Further examples of protein sources from vegetable origin are soy protein and pea protein. Sources of proteins may also be in form of protein isolates.
- the at least one other nutritional ingredient of the nutritional composition according to the invention is a protein that is from vegetable origin.
- Sources of carbohydrates may be mono-saccharides, disaccharides, oligosaccharides, and polysaccharides, their corresponding polyols and combinations of two or more thereof.
- Monosaccharides include glucose, fructose, xylose or galactose.
- Non-limiting examples of di-saccharides such as maltose, saccharose, lactose, isomaltulose and mixtures of two or more thereof.
- suitable polyols may include, sorbitol, mannitol, xylitol, erythritol, lactitol, mixtures of two or more thereof and the like.
- Oligosaccharides are saccharide polymers containing a small number, typically three to ten, monosaccharides.
- Non limiting examples of oligosaccharides are Fructooligosaccharides (FOS) and Galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), arabino-xylo-oligosaccharides (AXOS), manno-oligo-saccharides (MOS), and mixtures of two or more thereof.
- Polysaccharides comprise soluble and insoluble fibers.
- Polysaccharides can be glucose polymers such as starch and starch-derivatives, fructans derived from chicory or inulin, polydextrose, agar, galactomannans such as guar gum and locust bean gum, pectin, pectin derivatives, seaweed derived polysaccharides such as carrageenan, resistant starches, cereal fibres, fruit fibres and fibres of legumes, oat fibers and the like.
- Vitamins are essential micronutrients that an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet. Vitamins required by human metabolism are vitamin A, including all-trans-retinol, all-trans- retinyl-esters, as well as all-trans-beta-carotene and other provitamin A carotenoids, vitamin Bl (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid or folate), vitamin B 12 (cobalamins), vitamin C (ascorbic acid), vitamin D (calciferols), vitamin E (tocopherols and tocotrienols), and vitamin K (quinones).
- vitamin A including all-trans-retinol, all-trans- retinyl-esters, as well as
- Minerals are chemical elements required as essential nutrients by organisms to perform functions necessary for life.
- the major minerals in the human body are calcium, phosphorus, potassium, sodium, and magnesium.
- the trace elements that have a specific biochemical function in the human body are sulfur, iron, chlorine, cobalt, copper, zinc, manganese, molybdenum, iodine, and selenium.
- Essential amino acids are amino acids that cannot be synthesized de novo by the organism at a rate commensurate with its demand, and thus must be supplied in its diet.
- Examples of amino acids that cannot be synthesized by humans are phenylalanine, valine, threonine, tryptophan, methionine, leucine, isoleucine, lysine, and histidine.
- Other amino acids such as arginine, cysteine, glycine, glutamine, proline, and tyrosine can be limited under special pathophysiological conditions, such as prematurity in the infant or individuals in severe catabolic distress.
- Essential fatty acids are fatty acids that humans must ingest because the body requires them for good health but cannot synthesize them.
- Alpha-linolenic acid an omega-3 fatty acid
- linoleic acid an omega-6 fatty acid
- Further examples may include docosahexaenoic acid, arachidonic acid, eicosapentaenoic acid, and gamma-linolenic acid.
- the nutritional composition further comprises at least one non-nutritional ingredient.
- Non-nutritional ingredients according to the invention are ingredients that do not substantially add to the caloric intake and/or do not substantially provide micronutrients.
- examples of non-nutritional ingredients are flavors, colorants, emulsifiers, acid regulators such as citric acid or lactic acid, preservatives, and the like.
- the non-nutritional ingredients may be from a natural or synthetic origin.
- the nutritional composition does not contain ingredients from animal origin.
- the nutritional composition is a plant-based product.
- the nutritional composition according to the present invention has a fatty acid moiety that is closely resembling the fatty acid profile of human milk fat.
- very limited sources of palmitate are suitable alternatives to palm oil and bovine milk fat.
- Available sources such as cocoa butter, illipe fat or cottonseed oil will result in a too high increase of saturated fatty acids, and/or are not allowed to be used in infant formula.
- high-palmitic sunflower oil is a very good source of palmitate in the nutritional composition.
- Sunflower is an oilseed that is generally accepted for use in infant formula. Additionally, it will not result in a too high increase of saturated fatty acids.
- the invention also related to the use of high-palmitic sunflower oil in a nutritional composition, wherein the fatty acid moiety of the high-palmitic sunflower oil is comprising palmitic acid (Cl 6) in a range of from 20 to 45 wt.% and wherein the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a laity acid moiety comprising oleic acid (C18.1) in a range of from 45.0 to 65.0 wt.%, and a high-palmitic high- linoleic sunflower oil having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of from 35.0 to 55.0 wt.% and the high palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition.
- the fatty acid moiety of the high-palmitic sunflower oil is comprising palmitic acid (Cl 6) in
- Oil blends of comparative samples 1 and 2, and of the examples according to the invention are prepared according to the compositions as stated in table 1.
- the fatty acid profile of the oil blends is shown in table 2.
- the composition of each oil blend is made such as to mimic human milk fat as closely as possible.
- infant formulae are prepared according to standard “wet mix” process, known to the person skilled in the art.
- the oil blend as described in point 1 is mixed with lecithin to obtain an oil phase.
- the oil phase is kept at a temperature of about 60 °C.
- a water phase is prepared by mixing the soy protein concentrate and the maltodextnn in water.
- the water phase is also kept at about 60°C.
- An emulsion is prepared by mixing the water phase and the oil phase at a temperature of about 60°C, followed by a high-pressure homogenisation.
- the emulsion is pasteurized.
- the heat-sensitive vitamin- and mineral mix is added after the heat treatment.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pediatric Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
The present invention relates to a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient, wherein the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (C16) in an amount of from 20.0 to 45.0 wt.%, and wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising 1.0 to 8.0 wt.% of stearic acid (C18); 25.0 to 50.0 wt.% of oleic acid (C18.1); and 10.0 to 28.0 wt.%. of linoleic acid (C18.2). The present invention further relates to the use of the high-palmitic sunflower oil in a nutritional composition, and wherein the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil and a high-palmitic high-linoleic sunflower oil.
Description
NUTRITIONAL COMPOSITION
CROSS-REFERENCE TO RELATED APPLICATIONS
[0001] This application claims the benefit of European Application No. 22183441.9, filed July 6, 2022, U.S. which is incorporated by reference herein in its entirety.
FIELD OF THE INVENTION
[0002] The present invention relates to a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient.
BACKGROUND OF THE INVENTION
[0003] Nutritional compositions are compositions that are developed to cover the nutritional needs, of specific groups of people, such as preterm infants, infants, toddlers, elderly people, athletes, or human subjects having nutritional deficiencies and/or having a deficient immune system.
[0004] Nutritional compositions for early life nutrition aim to resemble human milk as much as possible, since human milk is generally seen as the ideal source of nutrition during early life. Early life nutrition and more specifically infant formula are nutritional compositions for formula-fed infants allowing a comparable growth and development as an exclusively breastfed infant. For this reason, in the early life compositions, not only the mam nutrients (proteins, lipids and carbohydrates), but also the trace elements (minerals, vitamins and etc.), must be carefully prepared to meet the infants’ nutritional needs.
[0005] One aspect wherein the nutritional compositions tend to resemble human milk fat as close as possible is its fatty acid profile. For that, a combination of vegetable and animal oils and/or fats may be used, including bovine milk fat, palm oil, palm oil fractions or combinations of two or more thereof.
[0006] There is however a growing consumer trend for reducing or completely banning from their diet ingredients from animal origin. Consumers switch towards plant-based alternatives because of various reasons such as health concerns, environmental concerns, sustainability or
animal welfare. Likewise, consumers also want to ban palm oil from their diet.
[0007] There is thus a need in the industry for nutritional compositions comprising alternative oils and/or fats such that the targeted fatty acid composition of the nutritional composition can be achieved. The present invention provides such a product.
SUMMARY OF THE INVENTION
[0008] The present invention relates to a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient, wherein the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 20.0 to 45.0 wt.%, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising:
• 1.0 to 8.0 wt.% of stearic acid (Cl 8);
• 25.0 to 50.0 wt.% of oleic acid (Cl 8.1); and
• 10.0 to 28.0 wt.%. of linoleic acid (C18.2).
[0009] The present invention further relates to the use of high-palmitic sunflower oil in a nutritional composition, wherein the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (C16) in an amount of from 20.0 to 45.0 wt.%, and wherein the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a fatty acid moiety comprising oleic acid (Cl 8.1) in a range of from 45.0 to 65.0 wt.%, and a high- palmitic high-linoleic sunflower oil having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of from 35.0 to 55.0 wt.% and the high palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition
DETAILED DESCRIPTION
[0010] The present invention relates to a nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient. The term “high-palmitic sunflower oil” in the present invention is encompassing sunflower oils having a fatty acid moiety comprising palmitic acid (C16) in an amount of from 20.0 to 45.0 wt.%, from 22.0 to 40.0 wt.%, or from 25
to 34.7 wt.%, and wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising:
• 1.0 to 8.0 wt.% of stearic acid (Cl 8);
• 25.0 to 50.0 wt.% of oleic acid (Cl 8.1); and
• 10.0 to 28.0 wt.%. of linoleic acid (C18.2).
[0011] The term “nutritional composition” according to the present invention encompasses compositions that are developed to cover nutritional needs of a human subject. The human subject can be a preterm infant, an infant, a toddler, a juvenile, an adolescent, an adult or an elderly subject. Furthermore, human subjects targeted for the nutritional composition according to the invention may relate to specific groups of people, such as, but not limited to athletes, or human subjects having nutritional deficiencies and/or having a deficient immune system. The nutritional compositions may also be designed for human subjects suffering a more specific disease state such as cancer, chronic obstructive pulmonary disease, and later-stage kidney disease or others. Amongst others, nutritional compositions may be helpful for people who struggle with a loss of appetite, have difficulty in chewing, have trouble preparing balanced meals, and/or are recovering from surgery or illness. In the event that the nutritional composition is meant for a complete nutrition, it can provide a healthy balance of protein, carbohydrate, and/or fat.
[0012] The nutritional compositions according to the invention may be in the form of a liquid, as a ready -to-drink nutritional composition, or used in feeding tubes. It can also be in the form of a formula base, i.e. a powder or a concentrated liquid, to be dissolved in water or in another fluid for the preparation of a ready-to-drink nutritional composition. The nutritional composition may also be in the form of a pudding or a j elly, or in the form of a cookie or a snack bar, or in any other form. Preferably the nutritional composition is a ready-to-drink nutritional composition, or a powder.
[0013] Preferably the nutntional composition according to the present invention is an early life nutritional composition, i.e. a composition that is particularly suitable for human subjects of 0 to 36 months of age.
[0014] The early life nutritional composition according to the present invention may be an infant formula (first age), for infants from birth to age of 6 months; a follow-on formula (second age), for infants from an age of 6 to 18 months, or a growing-up formula (third age) for infants from an age from 1 to 3 years.
[0015J In a more preferred aspect of the invention, the early life nutritional composition is a follow-on formula or growing-up formula.
[0016] The early life nutritional composition according to the invention may also be a preparation for special medical purposes such as, but not limited to, hypoallergenic formulae prepared from partially hydrolysed proteins, to prevent infants with a high risk of milk protein allergy' having an allergic reaction or a soy-based formulae prepared with soy protein isolates, for infants with lactose intolerance and/or galactosemia or for infants who are allergic to cow’s milk proteins. Further examples of early life nutritional composition according to the invention prepared for special medical purposes are nutrient-dense formulae enhanced in proteins, fats, minerals and vitamins for premature infants or low-birth-weight and elemental formulae, using free amino acids instead of proteins or peptides, for infants who are allergic to hydrolysed protein or soy, and the like.
[0017] The high-palmitic sunflower oil is a mixture of 2 or more high-palmitic sunflower oils. In case of a mixture of 2 or more high-palmitic sunflower oils it is understood that the fatty acid moiety of the mixture of the 2 or more high-palmitic sunflower oils has a content of palmitic acid (C16) in a range of from 20.0 to 45.0 wt.%, from 22.0 to 40.0 wt.%, or from 25 to 34.7 wt.%. [0018] The high-palmitic sunflower oil may be sourced from oilseeds of any sunflower (Helianthus annuus) line bearing oil which exhibits, following crushing and extraction, and in the absence of hydrogenation, or other chemical or physical modification, a fatty acid moiety having a suitable content of Cl 6. Examples of suitable sunflower oilseed lines are, but are not limited to, sunflower oilseed line IG-1297M or QQ-3598-M (EPl 185161), CAS-5 or CAS-12 (Serrano- Vega, M. (2005) Lipids, Vol. 40, p 369-374)
[0019] In one aspect of the invention the high palmitic sunflower oil is a mixture of a high- palmitic high-oleic sunflower oil and a high-palmitic high-linoleic sunflower oil
[0020] The term “high-palmitic high-oleic sunflower” oil is encompassing high-palmitic sunflower oil having a fatty acid moiety comprising oleic acid (C18.1) in a range of from 45.0 to 65.0 wt.%, from 48.0 to 62.0 wt.%, or from 50.0 to 60.0 wt.%. High-palmitic high-oleic sunflower oil may be sourced from oilseeds of a sunflower line such as, but not limited to, CAS-12, IG- 1297M or QQ-3598-M or a mixture of two or more thereof. The term “high-palmitic high-linoleic sunflower oil” is encompassing high-palmitic sunflower having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of from 35.0 to 55.0 wt.%, from 37.0 to 52.0 wt.%, or from 40.0
to 50.0 wt.%. High-palmitic high-linoleic sunflower oil may be sourced from oilseeds of a sunflower line such as CAS-5 or the like.
[0021] The high-palmitic sunflower oil may be present in an amount of from 25 to 95 wt.%, from 30 to 90 wt.% or from 35 to 80 wt.% of the total oil and/or fat content of the nutritional composition.
[0022] Preferably the high-palmitic sunflower oil is a mixture of a high-palmitic high- oleic sunflower oil and a high-palmitic high-linoleic sunflower oil, whereby the ratio of oleic acid over linoleic acid (C18.1/C18.2) is in a range of from 0.5 to 8.0, from 1.0 to 7.5, or from 1.5 to 6.5.
[0023] In one aspect of the invention, the high-palmitic sunflower oil is present as free oil in the nutritional composition.
[0024] In another aspect of the invention, the high-palmitic sunflower oil is present in the form of isolated or enlarged sunflower oleosomes.
[0025] Oleosomes, also known as "oil bodies", "lipid bodies", "lipid droplets" or "spherosomes", are pre-emulsified droplets or vesicles of oil stored in plant seeds and used as energy source for plant growth and metabolism. Oleosomes are typically extracted from cells by a process of grinding the seeds and subsequently washing, filtering and homogenizing the ground seeds to form an aqueous suspension. Said suspension is centrifuged to separate the oleosomes, called isolated oleosomes.
[0026] “Isolated oleosomes” as used in the present description means oleosomes that have been isolated/removed from their natural source of high-palmitic sunflower seeds. The term encompasses oleosomes isolated from a single oilseed line, as well as blends of oleosomes that are isolated from more than one oilseed line.
[0027] Typically, isolated high-palmitic sunflower oleosomes in the nutritional composition of the present invention may have an average globule diameter of about 1.5 to 2.5 micron.
[0028] “Enlarged oleosomes” as used in the present description means oleosomes that have been isolated/removed from their natural source and that have been subsequently subjected to a process for increasing their average globule size. Examples of processes for enlarging the average globule size of oleosomes are for example described in WO2021126408.
[0029] The enlarged high-palmitic sunflower oleosomes in the nutritional composition of the present invention may have an average globule diameter of the oleosomes in a range of from
more than 2.5 to 15.0 micron, preferably from 3.0 to 12.0 micron, more preferably from 4.0 to 10.0 micron. Such a globule size is important when being used for an early life nutritional composition, since it mimics the average globule size of human breast milk of about 5.0 micron. [0030] The average globule diameter of isolated or enlarged oleosomes is expressed as the D50-value (D50). The D50-value of oleosomes is the diameter below which 50% of the volume of oleosome particles lies, and it is expressed in micron (= micrometer, symbol: pm). To measure the average globule diameter (D50-value) of the oleosomes, the oleosomes are considered spherical and in case of non-spherical oleosomes, the diameter is considered as being the largest dimension that can be measured between two opposite points on the surface thereof.
[0031] To be able to measure the globule diameter of the oleosomes, a Mastersizer 3000 from Malvern equipped with a Hydro module may be used. A refractive index of 1.47 is used to measure the oleosomes size. The concentration of the oleosomes in the buffer is such that an obscuration in the range from 8.0 to 8.5% in the Mastersizer equipment is obtained. Obscuration within the Mastersizer is the amount of light blocked or scattered, by the particles. Therefore, the oleosomes are diluted in a buffer solution containing 10 mM sodium phosphate, pH 7.4, and 1.0 weight% sodium dodecyl sulphate (SDS). To give some guidance, about 0.2 weight% of oleosomes is diluted in the buffer solution and the dilution is further adjusted to obtain the aforementioned obscuration. Once this optimal obscuration is obtained, the globule diameter is measured, and the average globule diameter (D50) is calculated.
[0032] The nutritional composition may further comprise oils and/or fats other than the high-palmitic sunflower oil. Sources of such oils and/orfats other than the high-palmitic sunflower oil may be from vegetable and/or animal origin or a combination thereof. These sources do not compnse high-palmitic sunflower oil having a fatty acid moiety with a content of palmitic acid (Cl 6) in a range of from 20 to 45 wt.%.
[0033] Sources of oils and/or fats other than the high-palmitic sunflower oil from animal origin include, but are not limited to milk fat, pork fat (lard), cattle and sheep fat (tallow), poultry fat, fish oil, krill oil and combinations of two or more thereof. Sources of these fats, other than the high-palmitic sunflower oil, from vegetable origin include, without any limitation, cocoa butter, com oil, cottonseed oil, groundnut oil, linseed oil, olive oil, palm, palm olein, palm stearin, rapeseed oil, high-oleic canola oil, rice bran oil, safflower oil (also known as flaxseed oil), sesame oil, soybean oil, sunflower oil, including mid- and high-oleic varieties of sunflower, high-stearic sunflower oil, coconut oil, palm kernel oil, MCT compositions (i.e. Medium Chain Triglyceride
with fatty acid chain lengths in range of C8 to C12), algae oil, yeast oil, and combinations of two or more thereof.
[0034] Oils, fats, or combinations of oils and/or fats other than the high-palmitic sunflower oil may be present to obtain the desired composition of fatty acids in the nutritional composition together with the high-palmitic sunflower oil. Especially a desired amount of mono- and polyunsaturated fatty acids and/or a desired amount of mid- and short chain fatty acids is targeted.
[0035] In one aspect of the invention, the total oil and/or fat content of the nutritional composition has a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 15 to 30 wt.%, from 16 to 28 wt.%, or from 18 to 26 wt.%. Next to the high-palmitic acid sunflower oil, other sources of palmitic acid, that may be comprised in the nutritional composition are amongst others palm oil, cottonseed oil, cocoa butter, illipe fat; olein or stearin fractions of palm oil, cottonseed oil, cocoa butter or illipe fat; and blends of 2 or more thereof.
[0036] In a preferred aspect of the invention, the nutritional composition is substantially free from palm oil or components sourced from palm oil. Components sourced from palm oil are for example single or multiple fractionated oleins, single or multiple fractionated stearins, palm mid fractions, interesterified palm, interesterified palm fractions, hydrogenated palm, hydrogentated palm fractions, any combination of 2 or more thereof, and the like.
[0037] Next to the high-palmitic high-oleic acid sunflower oil, other vegetable sources of oleic acid Cl 8.1, that may be comprised in the nutritional composition are amongst others high- oleic or mid-oleic sunflower oil, high-oleic canola oil, high-stearic high-oleic sunflower oil, olive oil, palm oil and olein fractions (single or multiple fractions) of palm oil, or a mixture of 2 or more thereof. Animal sources of oleic acid may be, but are not limited to, chicken fat or lard or a mixture of 2 or more thereof.
[0038] Next to the high-palmitic high-linoleic acid sunflower oil, other vegetable sources of linoleic acid Cl 8.2, that may be comprised in the nutritional composition are amongst others sunflower oil, safflower oil, soybean oil, com oil, canola oil, high-stearic high-linoleic sunflower oil, or a mixture of 2 or more thereof.
[0039] The total oil and/or fat content of the nutritional composition may have a fatty acid moiety that is further comprising caprylic (C8), capric (CIO), lauric (C12) and myristic (C14) acid in a combined content (C8+C10+C12+C14) of up to 20 wt.%, from 10 to 18 wt.%, or from 12 to 16 wt.%.
[0040J Sources of caprylic (C8), capric (CIO), lauric (C12) and/or myristic (C14) acid that may be comprised in the nutritional composition are typically lauric fats such as for example coconut oil, palmkemel oil; olein or stearin fractions of coconut oil or palmkernel oil; MCT compositions; cuphea oil, or a mixture of 2 or more thereof.
[0041] The total oil and/or fat content of the nutritional composition may have a fatty acid moiety that is further comprising alpha-linolenic acid (Cl 8.3) in a range of from 0.5 to 4.0 wt.%, from 0.6 to 3.5 wt.%, or from 0.7 to 3.0 wt.%.
[0042] Sources of Cl 8.3 that may be comprised in the nutritional composition are, but are not limited to flaxseed, canola oil, walnut oil or mixtures of 2 or more thereof.
[0043] The nutritional composition according to the invention comprises at least one nutritional ingredient other than the high-palmitic sunflower oil. Nutritional ingredients are ingredients that contribute to the caloric intake and/or provide micronutrients. Preferably, the at least one other nutritional ingredient of the nutritional composition according to the invention is selected from the group consisting of proteins, carbohydrates, minerals, trace elements, essential amino acids, essential fatty acids, vitamins, and mixtures of two or more thereof. More preferably, the at least one other nutritional ingredient is selected from the group consisting of proteins, carbohydrates, essential amino acids, essential fatty acids, vitamins, and mixtures of two or more thereof.
[0044] Sources of proteins may be from vegetable and/or animal origin. Protein sources from animal origin include, but are not limited to, lean meat, poultry, fish, eggs or dairy products like milk, yoghurt, cheese, whey proteins or caseinate. Protein sources from vegetable origin include, without any limitation, seeds, nuts, beans, legumes, such as lentils and chickpeas, grain and cereal-based products. Further examples of protein sources from vegetable origin are soy protein and pea protein. Sources of proteins may also be in form of protein isolates. Preferably, the at least one other nutritional ingredient of the nutritional composition according to the invention is a protein that is from vegetable origin.
[0045] Sources of carbohydrates may be mono-saccharides, disaccharides, oligosaccharides, and polysaccharides, their corresponding polyols and combinations of two or more thereof.
[0046] Monosaccharides include glucose, fructose, xylose or galactose. Non-limiting examples of di-saccharides, such as maltose, saccharose, lactose, isomaltulose and mixtures of two or more thereof.
[0047J Examples of suitable polyols may include, sorbitol, mannitol, xylitol, erythritol, lactitol, mixtures of two or more thereof and the like.
[0048] Oligosaccharides are saccharide polymers containing a small number, typically three to ten, monosaccharides. Non limiting examples of oligosaccharides are Fructooligosaccharides (FOS) and Galacto-oligosaccharides (GOS), xylo-oligosaccharides (XOS), arabino-xylo-oligosaccharides (AXOS), manno-oligo-saccharides (MOS), and mixtures of two or more thereof.
[0049] Polysaccharides comprise soluble and insoluble fibers. Polysaccharides can be glucose polymers such as starch and starch-derivatives, fructans derived from chicory or inulin, polydextrose, agar, galactomannans such as guar gum and locust bean gum, pectin, pectin derivatives, seaweed derived polysaccharides such as carrageenan, resistant starches, cereal fibres, fruit fibres and fibres of legumes, oat fibers and the like.
[0050] Vitamins are essential micronutrients that an organism needs in small quantities for the proper functioning of its metabolism. Essential nutrients cannot be synthesized in the organism, either at all or not in sufficient quantities, and therefore must be obtained through the diet. Vitamins required by human metabolism are vitamin A, including all-trans-retinol, all-trans- retinyl-esters, as well as all-trans-beta-carotene and other provitamin A carotenoids, vitamin Bl (thiamine), vitamin B2 (riboflavin), vitamin B3 (niacin), vitamin B5 (pantothenic acid), vitamin B6 (pyridoxine), vitamin B7 (biotin), vitamin B9 (folic acid or folate), vitamin B 12 (cobalamins), vitamin C (ascorbic acid), vitamin D (calciferols), vitamin E (tocopherols and tocotrienols), and vitamin K (quinones).
[0051] Minerals are chemical elements required as essential nutrients by organisms to perform functions necessary for life. The major minerals in the human body are calcium, phosphorus, potassium, sodium, and magnesium. The trace elements that have a specific biochemical function in the human body are sulfur, iron, chlorine, cobalt, copper, zinc, manganese, molybdenum, iodine, and selenium.
[0052] Essential amino acids are amino acids that cannot be synthesized de novo by the organism at a rate commensurate with its demand, and thus must be supplied in its diet. Examples of amino acids that cannot be synthesized by humans are phenylalanine, valine, threonine, tryptophan, methionine, leucine, isoleucine, lysine, and histidine.
[0053 J The synthesis of other amino acids, such as arginine, cysteine, glycine, glutamine, proline, and tyrosine can be limited under special pathophysiological conditions, such as prematurity in the infant or individuals in severe catabolic distress.
[0054] Essential fatty acids are fatty acids that humans must ingest because the body requires them for good health but cannot synthesize them. Alpha-linolenic acid (an omega-3 fatty acid) and linoleic acid (an omega-6 fatty acid) are essential for humans. Further examples may include docosahexaenoic acid, arachidonic acid, eicosapentaenoic acid, and gamma-linolenic acid.
[0055] In one aspect of the invention the nutritional composition further comprises at least one non-nutritional ingredient.
[0056] Non-nutritional ingredients according to the invention are ingredients that do not substantially add to the caloric intake and/or do not substantially provide micronutrients. Examples of non-nutritional ingredients are flavors, colorants, emulsifiers, acid regulators such as citric acid or lactic acid, preservatives, and the like. The non-nutritional ingredients may be from a natural or synthetic origin.
[0057] In a preferred aspect of the invention, the nutritional composition does not contain ingredients from animal origin. In other words, the nutritional composition is a plant-based product.
[0058] The nutritional composition according to the present invention has a fatty acid moiety that is closely resembling the fatty acid profile of human milk fat. In order to mimic the level of palmitate of human milk fat in the nutritional composition, very limited sources of palmitate are suitable alternatives to palm oil and bovine milk fat. Available sources such as cocoa butter, illipe fat or cottonseed oil will result in a too high increase of saturated fatty acids, and/or are not allowed to be used in infant formula. It has been found that high-palmitic sunflower oil is a very good source of palmitate in the nutritional composition. Sunflower is an oilseed that is generally accepted for use in infant formula. Additionally, it will not result in a too high increase of saturated fatty acids. By using a mixture of high-palmitic high-oleic and high-palmitic high- linoleic sunflower oil, it is possible to closely match the palmitic acid target and also closely match the desired amount of oleic and linoleic acid in the nutritional composition.
[0059] Furthermore, the invention also related to the use of high-palmitic sunflower oil in a nutritional composition, wherein the fatty acid moiety of the high-palmitic sunflower oil is comprising palmitic acid (Cl 6) in a range of from 20 to 45 wt.% and wherein the high palmitic
sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a laity acid moiety comprising oleic acid (C18.1) in a range of from 45.0 to 65.0 wt.%, and a high-palmitic high- linoleic sunflower oil having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of from 35.0 to 55.0 wt.% and the high palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition.
EXAMPLES
1. Oil blend
[0060] Oil blends of comparative samples 1 and 2, and of the examples according to the invention are prepared according to the compositions as stated in table 1.
Source of C16 in the oil blends is in the comparative examples 1 and 2 respectively palm oil and bovine milk fat. In the examples 1 and 2 according to the invention a blend of sunflower oil from 2 high-palmitic sunflower seed lines is used to replace palm oil or bovine milk fat as source of Cl 6.
* Fatty acid composition of bovine milk fat according to Hageman, J. (2019) Internat. Dairy J., Vol. 92, 37-49.
** Fatty acid composition of high-stearic high-linoleic sunflower oil CAS-3, and high-palmitic sunflower oil CAS-3 and CAS-12 according to Serrano-Vega, M. (2005) Lipids, Vol. 40, p 369- 374.
[0061] The fatty acid profile of the oil blends is shown in table 2. The composition of each oil blend is made such as to mimic human milk fat as closely as possible.
** Fatty acid composition of human milkfat (Europe) according to Hageman, J. (2019) Internat. Dairy J., Vol. 92, 37-49.
2. Nutritional compositions
[0062] The oil blends as described in point 1 are subsequently used in the preparation of an infant formula according to the following recipe:
• 15% Soy protein concentrate
• 59% Maltodextrin
• 25% Oil blend according to point 1
• 0.5% Lecithin
• QS Vitamins and minerals
3. Preparation of the nutritional compositions
[0063] The infant formulae are prepared according to standard “wet mix” process, known to the person skilled in the art.
• The oil blend as described in point 1 is mixed with lecithin to obtain an oil phase. The oil phase is kept at a temperature of about 60 °C.
• A water phase is prepared by mixing the soy protein concentrate and the maltodextnn in water. The water phase is also kept at about 60°C.
• An emulsion is prepared by mixing the water phase and the oil phase at a temperature of about 60°C, followed by a high-pressure homogenisation.
• The emulsion is pasteurized. The heat-sensitive vitamin- and mineral mix is added after the heat treatment.
• The emulsion is spray-dried and a powder is obtained.
Claims
CLAIMS A nutritional composition comprising high-palmitic sunflower oil and at least one other nutritional ingredient, wherein the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 20.0 to 45.0 wt.%, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising:
• 1.0 to 8.0 wt.% of stearic acid (Cl 8);
• 25.0 to 50.0 wt.% of oleic acid (Cl 8.1); and
• 10.0 to 28.0 wt.%. of linoleic acid (C18.2). The nutritional composition according to claim 1, and the high-palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition. The nutritional composition according to any one of the preceding claims, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety comprising 15 to 30 wt.% of palmitic acid (Cl 6). The nutritional composition according to any one of the preceding claims, wherein the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a fatty acid moiety comprising oleic acid (C18.1) in a range of from 45.0 to 65.0 wt.%, and a high-palmitic high-linoleic sunflower oil having a fatty acid moiety comprising linoleic acid (C18.2) in a range of from 35.0 to 55.0 wt.%.. The nutritional composition according to any one of the preceding claims, wherein the ratio of oleic acid over linoleic acid (C18.1/C18.2) is in a range of from 0.5 to 8.0, from 1.0 to 7.5, or from 1.5 to 6.5. The nutritional composition according to any one of the preceding claims, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is
further comprising caprylic (C8), capric (CIO), launc (C12) and myristic (C14) acid in a combined content of up to 20 wt.%. The nutritional composition according to any one of the preceding claims, wherein the total oil and/or fat content of the nutritional composition has a fatty acid moiety that is further comprising 0.5 to 4.0 wt.% of alpha-linolenic acid (Cl 8.3). The nutritional composition according to any one of the preceding claims, and the nutritional composition is substantially free from palm oil and/or components sourced from palm oil. The nutritional composition according to any one of the preceding claims, and the nutritional composition is a plant-based product. The nutritional composition according to any one of the preceding claims, wherein the at least one other nutritional ingredient is selected from the group of proteins, carbohydrates, essential amino acids, essential fatty acids, vitamins, or mixtures of two or more thereof. The nutritional composition according to any one of the preceding claims, wherein the high-palmitic sunflower oil is in the form of isolated and/or enlarged sunflower oleosomes. The nutritional composition according to claim 11, wherein the high-palmitic sunflower oleosomes have an average globule diameter in a range of from more than 2.5 to 15.0 micron. The nutritional composition according to any one of the preceding claims and the nutritional composition is an infant formula, a follow-on formula or a young child formula. Use of high-palmitic sunflower oil in a nutritional composition, wherein the high-palmitic sunflower oil is a sunflower oil having a fatty acid moiety comprising palmitic acid (Cl 6) in an amount of from 20 to 45 wt.% and wherein the high palmitic sunflower oil is a mixture of a high-palmitic high-oleic sunflower oil having a fatty acid moiety comprising oleic acid (Cl 8. 1) in a range of from 45.0 to 65.0 wt.%, and a high-palmitic high-linoleic sunflower oil having a fatty acid moiety comprising linoleic acid (Cl 8.2) in a range of
from 35.0 to 55.0 wt.% and the high palmitic sunflower oil is present in an amount of from 25 to 95 wt.% of the total oil and/or fat content of the nutritional composition.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP22183441.9 | 2022-07-06 | ||
EP22183441 | 2022-07-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2024011043A1 true WO2024011043A1 (en) | 2024-01-11 |
Family
ID=82399519
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2023/069231 WO2024011043A1 (en) | 2022-07-06 | 2023-06-28 | Nutritional composition |
Country Status (1)
Country | Link |
---|---|
WO (1) | WO2024011043A1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1185161A1 (en) | 1999-06-04 | 2002-03-13 | Consejo Superior de Investigaciones Cientificas | Oil from seeds with a modified fatty acid composition |
US20110061138A1 (en) * | 2007-12-21 | 2011-03-10 | Leonardo Velasco Varo | Sunflower Oil with High Heat Stability |
WO2016101891A1 (en) * | 2014-12-24 | 2016-06-30 | Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd | An oil/fat composition and a preparation method for the same |
WO2021126408A1 (en) | 2019-12-16 | 2021-06-24 | Cargill, Incorporated | Isolated oleosome composition and process for preparing it |
WO2021126407A1 (en) * | 2019-12-16 | 2021-06-24 | Cargill, Incorporated | Nutritional composition and process for preparing it |
-
2023
- 2023-06-28 WO PCT/US2023/069231 patent/WO2024011043A1/en unknown
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1185161A1 (en) | 1999-06-04 | 2002-03-13 | Consejo Superior de Investigaciones Cientificas | Oil from seeds with a modified fatty acid composition |
US20110061138A1 (en) * | 2007-12-21 | 2011-03-10 | Leonardo Velasco Varo | Sunflower Oil with High Heat Stability |
WO2016101891A1 (en) * | 2014-12-24 | 2016-06-30 | Wilmar (Shanghai) Biotechnology Research & Development Center Co., Ltd | An oil/fat composition and a preparation method for the same |
WO2021126408A1 (en) | 2019-12-16 | 2021-06-24 | Cargill, Incorporated | Isolated oleosome composition and process for preparing it |
WO2021126407A1 (en) * | 2019-12-16 | 2021-06-24 | Cargill, Incorporated | Nutritional composition and process for preparing it |
Non-Patent Citations (1)
Title |
---|
SERRANO-VEGA, M., LIPIDS, vol. 40, 2005, pages 369 - 374 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101424822B1 (en) | Nutritional supplement containing long-chain polyunsaturated fatty acids | |
ES2478869T3 (en) | Liquid enteral nutritional composition suitable for tube feeding | |
ES2346533T3 (en) | COMPOSITIONS AND METHODS OF FORMULATION OF ENTERAL FORMULAS CONTAINING SIALIC ACID. | |
IE55299B1 (en) | Fat compositions | |
US20040013787A1 (en) | Fat compositions for infant formula and methods therefor | |
TR201808714T4 (en) | Baby food containing docosahexaenoic acid and lutein. | |
CN109043513A (en) | Alimentation composition and application thereof containing structuring fatty globules | |
US20150237902A1 (en) | Infant formula for optimal growth, gastrointestinal protection and immunological protection of infants | |
RU2706963C2 (en) | Milk mixture containing breast milk oligosaccharides, polyunsaturated fatty acids, nucleotides and lutein | |
WO2013148688A1 (en) | Pea protein containing nutritional compositions | |
CN104427887A (en) | Nutritional compositions including rrr -alpha tocopherol and polyunsaturated fatty acids | |
EP3043658A1 (en) | Nutritional composition having lipophilic compounds with improved solubility and bioavailability | |
CN108601813B (en) | High calorie, high protein nutritional formulations comprising collagen | |
CN114945284A (en) | Nutritional composition and method of making the same | |
ES2594656T3 (en) | Stabilizer system for liquid nutritional compositions | |
WO2021231981A1 (en) | Infant formula | |
WO2015089009A1 (en) | Nutritional compositions containing rice protein together with pea and/or potato proteins | |
CN107846953A (en) | In the nutrition product with improved lipophilicity solubility and bioavilability of easy mixed form | |
CN114680179A (en) | High protein concentrated milk and its preparation method | |
CN104486952A (en) | Nutritional creamer composition | |
WO2024011043A1 (en) | Nutritional composition | |
CA3209353A1 (en) | Infant formulas containing human breast milk proteins | |
CN114680180A (en) | A concentrated emulsion containing low concentration plant phospholipid with high lipid digestibility | |
WO2015089007A1 (en) | Nutritional compositions containing brown rice protein | |
Bardosono et al. | Soy Plant-based Formula with Fiber: From Protein Source to Functional Food |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 23744648 Country of ref document: EP Kind code of ref document: A1 |